These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34143187)

  • 21. Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.
    Murrell D; Bossaer JB; Carico R; Harirforoosh S; Cluck D
    Int J Pharm Pract; 2017 Feb; 25(1):18-30. PubMed ID: 27569742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal efficacy of isavuconazole and liposomal amphotericin B in a rabbit model of Exserohilum rostratum meningoencephalitis: A preclinical paradigm for management of CNS phaeohyphomycosis.
    Petraitis V; Petraitiene R; Katragkou A; Maung BBW; Moradi PW; Sussman-Straus GE; Naing E; Kovanda LL; Finkelman MA; Walsh TJ
    Med Mycol; 2021 Feb; 59(2):189-196. PubMed ID: 33313821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
    Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of Isavuconazole for Invasive Mold Disease: Role of Galactomannan for Real-Time Monitoring of Therapeutic Response.
    Kovanda LL; Kolamunnage-Dona R; Neely M; Maertens J; Lee M; Hope WW
    Clin Infect Dis; 2017 Jun; 64(11):1557-1563. PubMed ID: 28472247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis.
    Antony SJ; Jurczyk P; Brumble L
    J Natl Med Assoc; 2006 Jun; 98(6):940-2. PubMed ID: 16775917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Posaconazole for chronic refractory coccidioidal meningitis.
    Schein R; Homans J; Larsen RA; Neely M
    Clin Infect Dis; 2011 Dec; 53(12):1252-4. PubMed ID: 21987729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect.
    Warn PA; Sharp A; Parmar A; Majithiya J; Denning DW; Hope WW
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3453-61. PubMed ID: 19451288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Wu X; Clancy CJ; Rivosecchi RM; Zhao W; Shields RK; Marini RV; Venkataramanan R; Nguyen MH
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of amphotericin B lipid complex with amphotericin B and SCH 39304 in the treatment of murine coccidioidal meningitis.
    Allendoerfer R; Yates RR; Sun SH; Graybill JR
    J Med Vet Mycol; 1992; 30(5):377-84. PubMed ID: 1469539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report.
    Adamsick ML; Elshaboury RH; Gift T; Mansour MK; Kotton CN; Gandhi RG
    Transpl Infect Dis; 2019 Apr; 21(2):e13048. PubMed ID: 30636363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
    Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
    Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
    Rybak JM; Marx KR; Nishimoto AT; Rogers PD
    Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct in vitro comparison of the prodrug isavuconazonium sulfate with the isavuconazole active compound against Aspergillus spp. and 2 rare moulds.
    Pfaller MA; Rhomberg PR; Castanheira M
    Diagn Microbiol Infect Dis; 2018 Sep; 92(1):43-45. PubMed ID: 29735424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of isavuconazole at different target sites in healthy volunteers after single and multiple intravenous infusions.
    Bergmann F; Wölfl-Duchek M; Jorda A; Al Jalali V; Leutzendorff A; Sanz-Codina M; Gompelmann D; Trimmel K; Weber M; Eberl S; Van Os W; Minichmayr IK; Reiter B; Stimpfl T; Idzko M; Zeitlinger M
    J Antimicrob Chemother; 2024 May; 79(5):1169-1175. PubMed ID: 38546795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful isavuconazole salvage therapy in a patient with invasive mucormycosis.
    Ervens J; Ghannoum M; Graf B; Schwartz S
    Infection; 2014 Apr; 42(2):429-32. PubMed ID: 24217961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coccidioidal meningitis in non-AIDS patients. A case series at a Mexican neurological referral center.
    Cárdenas G; Aristizábal S; Salinas C; Delgado-Hernández R; Angeles-Morales V; Soto-Hernández J; Castañón-Olivares LR; Hernández F
    Clin Neurol Neurosurg; 2020 Sep; 196():106011. PubMed ID: 32593044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isavuconazole Diffusion in Infected Human Brain.
    Rouzaud C; Jullien V; Herbrecht A; Palmier B; Lapusan S; Morgand M; Guéry R; Dureault A; Danion F; Puget S; Goldwirt L; Lanternier F; Lortholary O
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isavuconazonium sulfate for the treatment of fungal infection.
    Walker RC; Zeuli JD; Temesgen Z
    Drugs Today (Barc); 2016 Jan; 52(1):7-16. PubMed ID: 26937491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
    Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
    Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis.
    Stewart ER; Eldridge ML; McHardy I; Cohen SH; Thompson GR
    Mycopathologia; 2018 Jun; 183(3):619-622. PubMed ID: 29340909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.